June 04, 2026 11:00 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Was it directed by ruling ecosystem?': Congress questions LIC stake in Rajesh Exports under SEBI scanner | Boost for Congress! Vijay allots Tamil Nadu's lone Rajya Sabha seat to key ally | Fresh trouble for Mamata: Complaint filed over explosive Amit Shah claim in Osman Hadi case | 'Communication gap': Rajesh Exports rejects SEBI allegations, says revenues were not overstated | ₹15.2 lakh crore revenue questioned! SEBI action sends Rajesh Exports shares tumbling | 'If not now, when!': Sonam Wangchuk backs Cockroach Janta Party protest; spokespersons named ahead of founder Abhijeet Dipke's India return | Cabinet approves Rs. 10,000 crore support package to stabilise ATF prices for airlines | Delhi hotel inferno kills 21, many foreign nationals among victims | Mamata's TMC splits wide open as 58 MLAs back expelled Ritabrata as Bengal LoP | Cockroach Janta Party goes offline: Abhijeet Dipke set to return to Delhi, plans Jantar Mantar protest over exam lapses
Pharma
Image Credit: freestocks via Unsplash

18 pharma companies lose licence for manufacturing spurious drugs

| @indiablooms | Mar 29, 2023, at 06:22 am

New Delhi: The government has cancelled the licences of 18 pharma companies for producing spurious and adulterated drugs, following joint inspections by central and state regulators at 76 drug manufacturers, a media report said.

The inspections were conducted across 20 states and Union territories in the past 15 days, the report said citing officials.

This is just the initial phase in the crackdown on companies involved in producing substandard medicines.

The authorities have cancelled the licences of 18 companies, while 26 companies have been issued show-cause notices, said the report.

During the drive, the regulators identified 203 firms. Most of the companies are from Himachal Pradesh (70), followed by Uttarakhand (45) and Madhya Pradesh (23), said the report.

Recently, some Indian pharma companies have come under the scanner of national and state drug regulators after drugs exported by them triggered negative reports.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.